Focus
cancer detection
FDA Approves DNA-Based Cancer Predisposition Test for Marketing
The test uses ‘next-generation sequencing’ to identify the hereditary risks of cancers as well.
|
FDA Approves DNA-Based Cancer Predisposition Test for Marketing
The test uses ‘next-generation sequencing’ to identify the hereditary risks of cancers as well.
|